A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
Clinical trial NCT02392507 · COMPLETED
Trial details
- NCT number
- NCT02392507
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-12
- Primary completion
- 2018-01-29
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.